BACK TO TOP
KSE100
169,043.19
1021.39
(0.61%)
KSE100PR
51,042.94
284.87
(0.56%)
ALLSHR
102,244.62
687.69
(0.68%)
KSE30
50,297.78
306.30
(0.61%)
KMI30
240,616.55
1662.76
(0.70%)
BKTI
46,865.56
262.97
(0.56%)
OGTI
34,899.40
593.22
(1.73%)
KMIALLSHR
66,324.04
491.93
(0.75%)
PSXDIV20
77,132.53
279.76
(0.36%)
UPP9
59,984.29
238.21
(0.40%)
NITPGI
44,813.57
273.78
(0.61%)
NBPPGI
48,186.17
301.62
(0.63%)
MZNPI
30,078.53
236.98
(0.79%)
JSMFI
41,757.61
477.81
(1.16%)
ACI
21,676.45
222.20
(1.04%)
JSGBKTI
71,192.44
482.87
(0.68%)
HBLTTI
19,055.52
16-09-2026
20.39
(0.11%)
MII30
21,784.71
144.55
(0.67%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.314.61
3.28
(1.05%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Sep 17, 2026 3:46 PM
REG
DFC
CSF
ODL
Open
312.00
High
316.50
Low
309.00
Volume
174,861
CIRCUIT BREAKER
280.20 — 342.46
DAY RANGE
309.00 — 316.50
52-WEEK RANGE ^
293.09 — 459.94
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
311.33
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM) **
9.62
1-Year Change * ^
-23.62%
YTD Change * ^
-19.29%
Last update: Thu, Sep 17, 2026 3:35 PM
Open
315.00
High
315.00
Low
315.00
Close
315.00
Change
0.00%
LDCP
315.00
Volume
5,000
Total Trades
7
CIRCUIT BREAKER
283.50 — 346.50
DAY RANGE
315.00 — 315.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Dmytro OliinykChairperson
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
100,192,990.33
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Sep 15, 2026Shariah Disclosure for the Half Year ended June 30, 2026 View   PDF
Aug 28, 2026Transmission of Quarterly Report for the Period ended June 30, 2026 View   PDF
Aug 25, 2026Financial Results for the Quarter Ended June 30, 2026 View   PDF
Apr 29, 2026Transmission of Quarterly Financial Statements for the Period ended March 31, 2026 View   PDF
Apr 27, 2026Financial Results for the Quarter Ended March 31, 2026 View   PDF
DateTitleDocument
Aug 18, 2026Board Meeting View   PDF
Apr 30, 2026Certified True Copy of The Resolutions passed by the shareholders in the Annual General Meeting held on April 30, 2026 View   PDF
Apr 20, 2026Board Meeting Quarter 1- 2026 View   PDF
Apr 9, 2026Notice of the Annual General Meeting View   PDF
Apr 8, 2026Prior Publication of Annual General Meeting Notice View   PDF
DateTitleDocument
Sep 11, 2026Credit of Interim Cash Dividend View   PDF
Sep 3, 2026Appointment of Chief Financial Officer View   PDF
Aug 28, 2026Appointment of Executive Director View   PDF
Aug 28, 2026Notice of interim cash dividend and share book closure View   PDF
Aug 27, 2026Prior Publication of Notice of Interim Cash Dividend and Share Book Closure View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales65,900,90161,187,50149,661,27741,841,585
Profit after Taxation10,025,3156,536,047533,9532,462,892
EPS31.4820.521.687.73
Q2 2026Q1 2026Q3 2025Q2 2025
Sales14,490,96717,028,32514,188,00814,720,667
Profit after Taxation1,969,9392,610,7042,037,2852,068,811
EPS6.198.206.406.50
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)37.0025.157.0517.40
Net Profit Margin (%)15.2110.681.085.89
EPS Growth (%)53.411,121.43(78.27)(54.02)
PEG0.230.02(0.63)(0.21)

Payouts

Financial Reports